KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

BeOne Medicines (ONC) Assets Average: 2016-2025

Historic Assets Average for BeOne Medicines (ONC) over the last 10 years, with Sep 2025 value amounting to $7.0 billion.

  • BeOne Medicines' Assets Average rose 20.69% to $7.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 billion, marking a year-over-year increase of 20.69%. This contributed to the annual value of $5.9 billion for FY2024, which is 3.90% up from last year.
  • BeOne Medicines' Assets Average amounted to $7.0 billion in Q3 2025, which was up 14.75% from $6.1 billion recorded in Q2 2025.
  • BeOne Medicines' 5-year Assets Average high stood at $8.3 billion for Q1 2022, and its period low was $5.4 billion during Q3 2021.
  • Over the past 3 years, BeOne Medicines' median Assets Average value was $5.8 billion (recorded in 2024), while the average stood at $5.9 billion.
  • Per our database at Business Quant, BeOne Medicines' Assets Average soared by 101.11% in 2021 and then crashed by 30.92% in 2023.
  • BeOne Medicines' Assets Average (Quarterly) stood at $6.9 billion in 2021, then dropped by 11.68% to $6.1 billion in 2022, then fell by 7.18% to $5.7 billion in 2023, then rose by 3.72% to $5.9 billion in 2024, then climbed by 20.69% to $7.0 billion in 2025.
  • Its last three reported values are $7.0 billion in Q3 2025, $6.1 billion for Q2 2025, and $5.9 billion during Q1 2025.